MIRA
INFORM REPORT
|
Report Date : |
24.07.2014 |
IDENTIFICATION DETAILS
|
Name : |
SAVA HEALTHCARE LIMITED (w.e.f. 27.11.2012) |
|
|
|
|
Formerly Known
As : |
SAVA HEALTHCARE PRIVATE LIMITED (w.e.f. 08.10.2012) BIODEAL LABORATORIES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Shed No.508, GIDC 2, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on)
: |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
21.02.1989 |
|
|
|
|
Com. Reg. No.: |
04-011921 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 73.215 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24231GJ1989PLC011921 |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACB8943J |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturing and Trading of Pharmaceutical Products. |
|
|
|
|
No. of Employees
: |
100 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
B (29) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having a moderate track record. Reserves of the company seems to be low. However, trade relations are reported as fair. Business is active.
Payment terms are slow but correct. The company can be considered for business dealings with some caution. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
INDIAN ECONOMIC OVERVIEW
N E W S
The economy grew 4.7 %in 2013/14, marking a
second straight year of sub-5 % growth – the worst slowdown in more than a
quarter of a century. The data was below an official estimate of 4.9 % annual
growth and compared with 4.5 % in the last fiscal year. However, the current
account deficit narrowed sharply to $ 32.4 billion at 1.7 % of gross domestic
product, in 2013/14 from a record high of $ 98.8 billion or 4.7 %, the year
before.A sharp fall in gold imports due to restrictions on overseas purchases
and muted import of capital goods helped shrink the current account deficit.
Online retailer Flipkart has acquired fashion
portal Myntra as it prepares to battle with the rapidly expanding India arm of
the global e-commerce giant Amazon. The company raised $ 210 million from
Russian Investment firm DST Global which has also invested in companies like
Facebook, Twitter and Alibaba Group.
General Motors will start exporting vehicles
from its Talegaon plant near Pune in the second half of 2014. GM was one of the
few global carmakers that was using its India plant only for the domestic
market.
Google has overtaken Apple as the world’s top
brand in terms of value, according to global market research agency Millward
Brown. Google’s brand value shot up 40 % in a year to $ 158.84 billion. The top
10 of the 100 slots were dominated by US companies.
Infosys lost another heavy weight when B G
Srinivas, a board member put in his papers. He is the third CEO-hopeful to quit
after Chairman N R Narayana Murthy’s return to the company – Ashok Vemuri and V
Balakrishnan being the other two.While Vemuri went on to lead IGate,
Balakrishnan joined politics.
Naresh Goyal – promoted Jet Airways posted
biggest quarterly loss – Rs 2153.37 crore – in the three months ended March 31,
mainly because it has been offering discounts to passengers to fill planes.
William S Pinckney – Chairman and CEO of
Amway India was arrested by the Andhra Pradesh Police in connection with a
complaint against the direct selling firm. This is the second time that he has
been taken into custody. A year, ago the Kerala Police had arrested Pinckney
and two company directors on charges of financial irregularities.
China has told its state-owned enterprises to
sever links with American consulting firms after the United States charged five
Chinese military officers wih hacking US companies. China’s action which
targets consultancies like McKinsey & Co. and the Boston Consulting Group,
sterns from fears that the first are providing trade secrets to the US
governments.
India has emerged as a country with some of
the highest unregistered businesses in the world. Indonesia has the maximum
number of shadow businesses, says a study of 68 countries by Imperial College
Business School in London.
Pfizer has abandoned its attempt to buy
AstraZeneca for nearly $ 118 billion after the latter refused an offer of 55
pounds a share.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CARE |
|
Rating |
Long term bank facilities : “BB-” |
|
Rating Explanation |
Have moderate risk of default. |
|
Date |
15.05.2014 |
|
Rating Agency Name |
CARE |
|
Rating |
Short term bank facilities : “A4” |
|
Rating Explanation |
Have minimal degree of safety and carry very
high credit risk. |
|
Date |
15.05.2014 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION PARTED BY
|
Name : |
Mr. Kamlesh Thakore |
|
Designation : |
Accounts Executive |
|
Contact No.: |
91-2752-243730 |
|
Date : |
23.07.2014 |
LOCATIONS
|
Registered Office/ Factory 1 : |
Shed No.508, GIDC 2, Wadhawan City, District Surendranagar – 363035,
Gujarat, India |
|
Tel. No.: |
91-2752-243730/ 1/ 2 |
|
Fax No.: |
91-2752-243733 |
|
E-Mail : |
pratiksha.talathi@savaglobal.com |
|
Website : |
|
|
Location : |
Owned |
|
Locality : |
Commercial |
|
|
|
|
Factory 2 : |
507B-512, GIDC Estate, Wadhwan City, Surendranagar – 363035, Gujarat,
India |
|
Tel. No.: |
91-2752-243730/ 1/ 2 |
|
|
|
|
Corporate / Marketing Office : |
Lalwani Plaza, Wing B, Sakorenagar CHS, Sava House, Off New Airport
Road, Viman Nagar, Pune – 411014, Maharashtra, India |
|
Tel. No.: |
91-20-30516100 |
|
Fax No.: |
91-20-30516161 |
|
E-Mail : |
DIRECTORS
As on 30.09.2013
|
Name : |
Mr. Vinod Ramchandra Jadhav |
|
Designation : |
Managing Director |
|
Address : |
Plot No.7, Windsor Estate, S. No.17/2B, Near Bishop School, Vadgaon Sheri, Pune – 411014, Maharashtra, India |
|
Date of Birth/Age : |
21.02.1972 |
|
Qualification : |
Diploma in Engineering |
|
Date of Appointment : |
25.10.2010 |
|
PAN No. : |
AANPJ0592P |
|
DIN No.: |
00022790 |
|
|
|
|
Name : |
Mr. Shailesh Ramanlal Shah |
|
Designation : |
Additional Director |
|
Address : |
E/303, 10 Kastur Kunj, CTS 2745 to 2755, Shivaji Nagar, Pune – 411005,
Maharashtra, India |
|
Date of Birth/Age : |
21.10.1950 |
|
Qualification : |
CA |
|
Date of Appointment : |
03.06.2011 |
|
PAN No. : |
ANUPS4287N |
|
DIN No.: |
00181435 |
|
|
|
|
Name : |
Mr. Vishal Ramchandra Jadhav |
|
Designation : |
Director |
|
Address : |
C-1/101, Lunkad Queens Land, Viman Nagar, Pune – 411014, Maharashtra,
India |
|
Date of Birth/Age : |
31.01.1977 |
|
Qualification : |
B. Com |
|
Date of Appointment : |
27.02.2012 |
|
PAN No.: |
AGMPJ5005A |
|
DIN No. : |
05235986 |
KEY EXECUTIVES
|
Name : |
Pratiksha Ulhas Talathi |
|
Designation : |
Secretary |
|
Address : |
94, Shakuntal Mayur Colony, Kothrud, Pune – 411038, Maharashtra, India |
|
Date of Birth/Age : |
28.02.1988 |
|
Date of Appointment : |
26.11.2012 |
|
PAN No. : |
AFSPT8735J |
|
|
|
|
Name : |
Mr. Kamlesh Thakore |
|
Designation : |
Accounts Executive |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2013
|
Names of Equity Shareholders |
No. of Shares |
|
Vinod Ramchandra Jadhav |
33680 |
|
Anagha Pharma Private Limited |
6387820 |
|
Suvarna Vinod Jadhav |
450000 |
|
Vishal Ramchandra Jadhav |
1 |
|
Deepak Laxman Shinde |
1 |
|
Raju Laxman Shinde |
1 |
|
Shanta Jadhav |
1 |
|
Total |
6871504 |
|
Names of Preference Shareholder |
No. of Shares |
|
Anagha Pharma Private Limited |
450000 |
|
Total |
450000 |
As on 30.09.2013
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage of Holding |
|
Bodies corporate |
92.96 |
|
Directors or relatives of Directors |
7.04 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing and Trading of Pharmaceutical Products. |
||||
|
|
|
||||
|
Products : |
|
||||
|
|
|
||||
|
Exports : |
|
||||
|
Products : |
Finished Goods |
||||
|
Countries : |
· Malaysia Ukraine |
||||
|
|
|
||||
|
Imports : |
|
||||
|
Products : |
Raw Material |
||||
|
Countries : |
Germany |
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
L/C and Credit |
||||
|
|
|
||||
|
Purchasing : |
L/C and Credit |
GENERAL INFORMATION
|
No. of Employees : |
100 (Approximately) |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Bankers : |
· Yes Bank Limited, 9th Floor, Nehru Centre, Discovery Of India,Dr. Annie Besant Road, Worli, Mumbai - 400018, Maharashtra, India UCO Bank, Mid Corporate Branch, Mumbai - Pune Road,
Pimpri, Pune -411018, Maharashtra, India Axis Bank Limited, Pune,
Maharashtra, India |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Facilities : |
NOTE LONG TERM
BORROWINGS Charge on current assets and movable fixed assets both present and future, equitable mortgage of lease hold land, personal guarantees of directors and corporate guarantee of Anagha Pharma Private Limited and charge over personal investment of Rs. 70.000 Millions held by certain Directors of the Company The Company has availed vehicle loan from ICICI bank of Rs. 0.870 Millions (2012:1.288 Millions) which carries interest ranging between 10.79% p.a. to 11.45% p.a. repayable in 36 equated installments of Rs. 44,508 per month commencing from 1 March 2012. SHORT TERM
BORROWINGS Working capital loan from bank represeting overdraft
facility is secured against first pari pasu charge on current assets and
movable fixed assets both present and future, equitable mortgage of lease
hold land, personal guarantees of directors and corporate guarantee of Anagha
Pharma Private Limited and charge over personal investment of Rs. 70.000
Millions held by certain Directors of the Company. The overdraft facility is
repayable on demand and carry an interest of 14% p.a. |
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
MZSK and Associates Chartered Accountants |
|
Address : |
102 First Floor, Ganraj Market, Plot No. 438 To 441 Gate No. 2, Market Yard, Pune - 411037, Maharashtra, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AACFK3470E |
|
|
|
|
Holding Company : |
ANAGHA PHARMA PRIVATE LIMITED U51397GJ2004PTC074963 |
|
|
|
|
Enterprises which are
owned, or have significant influence of or are partners with Key management
personnel and their relatives : |
· Sava Medica Limited CIN No.: U74999PN2010PLC135514 Sava Private Limited CIN No.: U72900GJ2009PTC074961 Sava Biopharm Limited CIN No.: U74900PN2011PLC141236 Goldwings Trading FZE |
CAPITAL STRUCTURE
As on 31.03.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
7,000,000 |
Equity Shares |
Rs.10/- each |
Rs. 70.000 Millions |
|
7,000,000 |
9% Non Cumulative Redeemable Preference Shares |
Rs.10/- each |
Rs. 50.000 Millions |
|
|
|
|
|
|
|
Total |
|
Rs. 120.000
Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
6,871,504 |
Equity Shares |
Rs.10/- each |
Rs. 68.715 Millions |
|
450,000 |
9% Non Cumulative Redeemable Preference Shares |
Rs.10/- each |
Rs. 4.500 Millions |
|
|
|
|
|
|
|
Total |
|
Rs. 73.215
Millions |
FINANCIAL DATA
[all figures are in
Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders'
Funds |
|
|
|
|
(a) Share Capital |
73.215 |
5.100 |
5.100 |
|
(b) Reserves & Surplus |
11.628 |
(4.597) |
17.411 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2)
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
84.843 |
0.503 |
22.511 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
119.804 |
126.019 |
22.241 |
|
(b) Deferred tax liabilities (Net) |
4.523 |
8.107 |
7.860 |
|
(c) Other long term liabilities |
0.000 |
7.491 |
0.000 |
|
(d) long-term provisions |
1.310 |
0.337 |
0.000 |
|
Total Non-current Liabilities (3) |
125.637 |
141.954 |
30.101 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
122.076 |
67.898 |
136.354 |
|
(b) Trade payables |
106.045 |
62.068 |
25.956 |
|
(c) Other current
liabilities |
97.895 |
46.435 |
46.133 |
|
(d) Short-term provisions |
5.025 |
0.013 |
0.000 |
|
Total Current Liabilities (4) |
331.041 |
176.414 |
208.443 |
|
|
|
|
|
|
TOTAL |
541.521 |
318.871 |
261.055 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
304.511 |
131.770 |
133.241 |
|
(ii) Intangible Assets |
1.816 |
1.965 |
0.000 |
|
(iii) Capital
work-in-progress |
27.678 |
8.776 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
18.903 |
22.488 |
7.045 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current Assets |
352.908 |
164.999 |
140.286 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
95.124 |
86.840 |
36.852 |
|
(c) Trade receivables |
61.993 |
37.708 |
45.361 |
|
(d) Cash and cash
equivalents |
9.706 |
8.719 |
11.179 |
|
(e) Short-term loans and
advances |
21.790 |
20.605 |
27.377 |
|
(f) Other current assets |
0.000 |
0.000 |
0.000 |
|
Total Current Assets |
188.613 |
153.872 |
120.769 |
|
|
|
|
|
|
TOTAL |
541.521 |
318.871 |
261.055 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
367.638 |
273.841 |
252.874 |
|
|
|
Other Income |
9.778 |
6.452 |
8.354 |
|
|
|
TOTAL |
377.416 |
280.293 |
261.228 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
184.159 |
158.742 |
110.671 |
|
|
|
Purchases of Stock-in-Trade |
0.667 |
2.863 |
3.829 |
|
|
|
Changes in inventories of finished goods, work-in-progress
and Stock-in-Trade |
(1.270) |
(21.548) |
-0.790 |
|
|
|
Employees benefits expense |
55.650 |
39.287 |
17.493 |
|
|
|
Other expenses |
79.384 |
86.310 |
62.008 |
|
|
|
TOTAL |
318.590 |
265.654 |
193.211 |
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
58.826 |
14.639 |
68.017 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
17.538 |
16.689 |
17.334 |
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
41.288 |
(2.050) |
50.683 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
28.486 |
19.712 |
18.701 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
12.802 |
(21.762) |
31.982 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
(3.422) |
0.246 |
10.740 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
16.224 |
(22.008) |
21.242 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
136.153 |
92.064 |
84.741 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
RM Materials |
NA |
NA |
0.000 |
|
|
|
PM Materials |
NA |
NA |
31.707 |
|
|
|
Capital Goods |
NA |
NA |
16.232 |
|
|
TOTAL IMPORTS |
NA |
NA |
47.939 |
|
|
|
|
|
|
|
|
|
|
Earnings /
(Loss) Per Share (Rs.) |
3.31 |
(366.80) |
41.65 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
PAT / Total Income |
(%) |
4.30 |
(7.85) |
8.13 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
3.48 |
(7.95) |
12.65 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
2.49 |
(7.02) |
12.25 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.15 |
(43.26) |
1.42 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
2.85 |
385.52 |
7.05 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
0.57 |
0.87 |
0.58 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Share Capital |
5.100 |
5.100 |
73.215 |
|
Reserves & Surplus |
17.411 |
(4.597) |
11.628 |
|
Net
worth |
22.511 |
0.503 |
84.843 |
|
|
|
|
|
|
long-term borrowings |
22.241 |
126.019 |
119.804 |
|
Short term borrowings |
136.354 |
67.898 |
122.076 |
|
Total
borrowings |
158.595 |
193.917 |
241.880 |
|
Debt/Equity
ratio |
7.045 |
385.521 |
2.851 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
252.874 |
273.841 |
367.638 |
|
|
|
8.291 |
34.252 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
252.874 |
273.841 |
367.638 |
|
Profit |
21.242 |
(22.008) |
16.224 |
|
|
8.40% |
(8.04%) |
4.41% |
LOCAL AGENCY FURTHER INFORMATION
CURRENT MATURITIES
OF LONG TERM DEBTS
|
Particulars |
31.03.2013 (Rs.
In Millions) |
31.03.2012 (Rs.
In Millions) |
31.03.2011 (Rs.
In Millions) |
|
|
|
|
|
|
Current Maturities of Long Term Debts |
NA |
14.690 |
0.000 |
|
|
|
|
|
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
----- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details
(if applicable) |
Yes |
|
21] |
Market information |
----- |
|
22] |
Litigations that the firm
/ promoter involved in |
----- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
----- |
|
26] |
Buyer visit details |
----- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director,
if available |
Yes |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
Yes |
INDEX OF CHARGES
|
S.NO. |
CHARGE ID |
DATE OF CHARGE
CREATION/MODIFICATION |
CHARGE AMOUNT
SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST
NUMBER (SRN) |
|
1 |
10434201 |
31/05/2013 * |
110,000,000.00 |
UCO BANK |
MID CORPORATE BRANCH, MUMBAI - PUNE ROAD, PIMPRI, |
B79444048 |
|
2 |
10324379 |
05/01/2012 * |
140,000,000.00 |
YES BANK LIMITED |
9TH FLOOR, NEHRU CENTRE, DISCOVERY OF INDIA, DR. |
B30952568 |
* Date of charge modification
UNSECURED LOANS
|
PARTICULAR |
31.03.2013 (Rs.
In Millions) |
31.03.2012 (Rs.
In Millions) |
|
LONG TERM
BORROWINGS |
|
|
|
Loans and advances from others |
82.750 |
71.726 |
|
|
|
|
|
SHORT TERM
BORROWINGS |
|
|
|
Loans and advances from others |
20.273 |
0.000 |
|
Total |
103.023 |
71.726 |
CHANGE IN NAME AND
CONVERSION TO PUBLIC COMPANY
The Company was incorporated as Private Limited Company with the name of Biodeal Laboratories Private Limited. Demerger process of the Company was completed on 5th January, 2012 consequent to which the management of the Company was completely transferred to the Sava group. In order to highlight affiliation of the Company with the Sava Group, its name was changed to Sava Healthcare Private Limited during the year.
Further, during the year the Company was also converted to Public Limited company consequent to which its name was changed to Sava Healthcare Limited.
FIXED ASSETS
Tangible Assets
Land
Buildings
Plant
and equipment
Furniture
and fixtures
Vehicles
Office
equipment
Computer
equipments
Other
equipments
Intangible Assets
Computer
software
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.18 |
|
|
1 |
Rs.102.68 |
|
Euro |
1 |
Rs.81.03 |
INFORMATION DETAILS
|
Information
Gathered by : |
PLK |
|
|
|
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
MRI |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
4 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
2 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
29 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to
overcome financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.